Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Maria Teresa Bochicchio
Observed names:
Bochicchio, Maria Teresa,
M Bochicchio,
M. Bochicchio,
M. T. Bochicchio,
M.T. Bochicchio,
maria Teresa Bochicchio
show all 6
Institution:
Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori
Observed institutions:
IRCCS Azienda Ospedliero-Universitaria di Bologna Policlinico di Sant'Orsola,
Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori,
Istituto di Ematologia di Bologna,
University of Brescia,
University of Bologna
ORCID:
0000-0001-9299-9189
Observed ORCID:
0000-0001-9299-9189
OpenAlex ID:
A5007779887
Unraveling the complexity of tyrosine kinase inhibitor–resistant populations by ultra-deep sequencing of the BCR-ABL kinase domain
2013
·
Simona Soverini
, Caterina De Benedittis
, et al.
·
Blood
·
174
Differences among young adults, adults and elderly chronic myeloid leukemia patients
2014
·
F. Castagnetti
, G. Gugliotta
, et al.
·
Annals of Oncology
·
106
PDF
The BCR‐ABL1 transcript type influences response and outcome in P hiladelphia chromosome‐positive chronic myeloid leukemia patients treated frontline with imatinib
2017
·
Fausto Castagnetti
, Gabriele Gugliotta
, et al.
·
American Journal of Hematology
·
105
PDF
Main changes in European Clinical Trials Regulation (No 536/2014)
2018
·
E. Tenti
, G. Simonetti
, et al.
·
Contemporary Clinical Trials Communications
·
56
PDF
Long-term outcome of a phase 2 trial with nilotinib 400 mg twice daily in first-line treatment of chronic myeloid leukemia
2015
·
G. Gugliotta
, F. Castagnetti
, et al.
·
Haematologica
·
45
Integrated genomic-metabolic classification of acute myeloid leukemia defines a subgroup with NPM1 and cohesin/DNA damage mutations
2021
·
Giorgia Simonetti
, Carlo Mengucci
, et al.
·
Leukemia
·
42
Response of high-risk MDS to azacitidine and lenalidomide is impacted by baseline and acquired mutations in a cluster of three inositide-specific genes
2019
·
Matilde Y. Follo
, Andrea Pellagatti
, et al.
·
Leukemia
·
42
PDF
Exploring the ATR-CHK1 pathway in the response of doxorubicin-induced DNA damages in acute lymphoblastic leukemia cells
2021
·
Andrea Ghelli Luserna Di Rorà
, Martina Ghetti
, et al.
·
Cell Biology and Toxicology
·
30
PDF
Cryptic BCR-ABL fusion gene as variant rearrangement in chronic myeloid leukemia: molecular cytogenetic characterization and influence on TKIs therapy
2017
·
Simona Luatti
, Carmen Baldazzi
, et al.
·
Oncotarget
·
30
Molecular Monitoring of BCR-ABL Transcripts after Allogeneic Stem Cell Transplantation for Chronic Myeloid Leukemia
2013
·
Mario Arpinati
, Giulia Tolomelli
, et al.
·
Transplantation and Cellular Therapy
·
29
Genetics and Pathogenetic Role of Inflammasomes in Philadelphia Negative Chronic Myeloproliferative Neoplasms: A Narrative Review
2021
·
Valeria Di Battista
, Maria Teresa Bochicchio
, et al.
·
International Journal of Molecular Sciences
·
28
PDF
Revealing very small FLT3 ITD mutated clones by ultra-deep sequencing analysis has important clinical implications in AML patients
2015
·
Elisa Zuffa
, Eugenia Franchini
, et al.
·
Oncotarget
·
28
PDF
Nilotinib 300 mg twice daily: an academic single-arm study of newly diagnosed chronic phase chronic myeloid leukemia patients
2016
·
F. Castagnetti
, M. Breccia
, et al.
·
Haematologica
·
24
PDF
Free radical-induced lipoperoxidation and severe head injury: A clinical study
1990
·
M. Bochicchio
, N. Latronico
, et al.
·
Intensive Care Medicine
·
22
Droplet Digital PCR for BCR–ABL1 Monitoring in Diagnostic Routine: Ready to Start?
2021
·
Maria Teresa Bochicchio
, Jessica Petiti
, et al.
·
Cancers
·
18
PDF
Targeting exhausted cytotoxic T cells through CTLA ‐4 inhibition promotes elimination of neoplastic cells in human myelofibrosis xenografts
2024
·
Lara Tavernari
, Sebastiano Rontauroli
, et al.
·
American Journal of Hematology
·
15
PDF
Novel strategies for the treatment of myelofibrosis driven by recent advances in understanding the role of the microenvironment in its etiology
2019
·
Zimran Eran
, Maria Zingariello
, et al.
·
F1000Research
·
15
PDF
Gimema ALL2418: Interim Analysis of a Phase Iia Study of Feasibility and Effectiveness of Inotuzumab Ozogamicin in Adult Patients with B-Cell Acute Lymphoblastic Leukemia with Positive Minimal Residual Disease before Any Hematopoietic Stem Cell Transplantation
2022
·
Giovanni Marconi
, Alfonso Piciocchi
, et al.
·
Blood
·
14
Platelets Contribution to Thrombin Generation in Philadelphia-Negative Myeloproliferative Neoplasms: The “Circulating Wound” Model
2021
·
Alessandro Lucchesi
, Roberta Napolitano
, et al.
·
International Journal of Molecular Sciences
·
11
PDF
Measurable Residual Disease and Clonal Evolution in Acute Myeloid Leukemia from Diagnosis to Post-Transplant Follow-Up: The Role of Next-Generation Sequencing
2023
·
Alessandra Sperotto
, Maria Teresa Bochicchio
, et al.
·
Biomedicines
·
10
PDF
MEC (mitoxantrone, etoposide, and cytarabine) induces complete remission and is an effective bridge to transplant in acute myeloid leukemia
2020
·
Giovanni Marconi
, Annalisa Talami
, et al.
·
European Journal Of Haematology
·
10
Uncovering the expression of circPVT1 in the extracellular vesicles of acute myeloid leukemia patients
2023
·
Martina Ghetti
, Ivan Vannini
, et al.
·
Biomedicine & Pharmacotherapy
·
8
PDF
Validation of the New European LeukemiaNet (ELN) Recommendations for Bcr-Abl Kinase Domain Mutation Analysis In Chronic Myeloid Leukemia: An Analysis of the GIMEMA CML Working Party Studies
2011
·
Simona Soverini
, Alessandra Gnani
, et al.
·
Blood
·
8
Exploring the role of PARP1 inhibition in enhancing antibody–drug conjugate therapy for acute leukemias: insights from DNA damage response pathway interactions
2024
·
Andrea Ghelli Luserna di Rorà
, Mouna Jandoubi
, et al.
·
Journal of Translational Medicine
·
7
PDF
Five-Year Results of Nilotinib 400 Mg BID in Early Chronic Phase Chronic Myeloid Leukemia (CML): High Rate of Deep Molecular Response - Update of the Gimema CML WP Trial CML0307
2012
·
Gianantonio Rosti
, Gabriele Gugliotta
, et al.
·
Blood
·
7
Show more works
View as search
Works count:
111
Citation count:
965
H-index:
15
I10-index:
21
Year
Topic
Type